glp-1 egfr cut off CKJ REVIEW receptor agonists in patients with chronic kidney disease and either overweight or obesit Glucagon-like peptide-1 receptor agonists and

Markey CH, August KJ, Malik D, Richeson A

24 Feb 2026

Patients should be aware that key safety considerations include: Hypersensitivity to the active substance or excipients Pregnancy or breastfeeding Risk of pancreatitis and gallbladder disease Potential for dehydration with severe gastrointestinal side effects A thorough medical assessment, including review of current medications and comorbidities, is essential before initiating treatment

Retraso del Vaciamiento Gstrico: Ozempic ralentiza el proceso mediante el cual los alimentos abandonan el estmago y pasan al intestino delgado

Listen to your body and focus on movement that feels restorative, not draining